GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/IBD/Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated December 1, 2025

Quick Answer

The study you are referring to explores the relationship between the inflammatory potential of overall dietary patterns and the risk of developing inflammatory bowel diseases (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC). Here's a detailed breakdown of the findings and implications: ### Objective of the Study: The primary goal of the study was to determine whether diets with varying inflammatory potential, as measured by the Inflammatory Score of...


The study you are referring to explores the relationship between the inflammatory potential of overall dietary patterns and the risk of developing inflammatory bowel diseases (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC). Here's a detailed breakdown of the findings and implications:

### Objective of the Study:

The primary goal of the study was to determine whether diets with varying inflammatory potential, as measured by the Inflammatory Score of the Diet (ISD), influence the risk of developing Crohn’s disease and ulcerative colitis. While prior research has focused on individual dietary components, this study examined dietary patterns as a whole to provide a more comprehensive understanding of the diet-disease relationship.

### Methodology:

1. **Data Source**: The study used data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, a large-scale, long-term study.

2. **Dietary Assessment**: Participants’ dietary intake was assessed at the study's baseline using validated food frequency questionnaires. These data were used to calculate ISD scores, which reflect the overall inflammatory potential of the diet.

3. **Follow-Up**: Participants were followed for over a decade to track the development of Crohn’s disease and ulcerative colitis.

4. **Statistical Analysis**: Cox proportional hazard models were employed to estimate associations between ISD scores and disease risk. The analysis adjusted for key confounding factors such as lifestyle, demographic, and behavioral variables.

### Key Findings:

1. **Crohn’s Disease (CD)**:

  • Diets with a **higher inflammatory potential** (higher ISD scores) were associated with an **increased risk of developing Crohn’s disease**.
  • The association was particularly pronounced among women.
  • Subgroup analyses revealed that the link between high ISD scores and Crohn’s disease was largely driven by **lower consumption of anti-inflammatory dietary components**, such as:
  • Fiber
  • Mono-unsaturated fatty acids
  • Vitamin C
  • Magnesium
  • Onion
  • Alcohol (in moderate amounts)

2. **Ulcerative Colitis (UC)**:

  • No significant association was found between the inflammatory potential of the diet and the risk of developing ulcerative colitis.
  • This suggests that the mechanisms driving Crohn’s disease and ulcerative colitis may differ in their relationship to dietary factors.

### Implications of the Study:

1. **Dietary Inflammatory Potential**:

  • The findings underscore the importance of considering the overall inflammatory potential of dietary patterns, rather than focusing solely on individual nutrients or foods, when assessing disease risk.
  • Pro-inflammatory dietary patterns, characterized by low intake of anti-inflammatory components, may contribute to the development of Crohn’s disease.

2. **Prevention Strategies**:

  • These results highlight the potential for dietary interventions to reduce the risk of Crohn’s disease, particularly in populations at higher risk.
  • Encouraging the consumption of anti-inflammatory foods, such as those rich in fiber, vitamins, and healthy fats, may be a valuable preventive strategy.

3. **Gender-Specific Findings**:

  • The stronger association observed in women suggests that sex-specific factors may play a role in the relationship between diet and Crohn’s disease risk. Further research may be needed to explore these differences in more detail.

4. **Differential Impact on IBD Subtypes**:

  • The lack of association between diet and ulcerative colitis risk suggests that dietary inflammatory potential may not be a universal risk factor for all forms of inflammatory bowel disease. This highlights the need for tailored approaches to understanding and managing different IBD subtypes.

### Conclusion:

The study provides strong evidence that diets with a high inflammatory potential are associated with an increased risk of Crohn’s disease, particularly among women, while no such association exists for ulcerative colitis. These findings emphasize the importance of dietary patterns in the prevention of Crohn’s disease and suggest that public health strategies should focus on promoting anti-inflammatory dietary components to mitigate disease risk. Further research is needed to explore the underlying mechanisms and to confirm these findings in diverse populations.

Related Q&A

IBD Across Ethnicities: Gastroenterology | July 2026

Introduction: The global incidence of inflammatory bowel disease (IBD) continues to rise, particularly in newly industrialized countries. This comprehensive systematic review evaluated how race, ethnicity, geography, and migration influence the clinical phenotype and outcomes of...

Moving Beyond the "Wait to Fail" Strategy in ASUC: FG | 2026

Introduction: Acute severe ulcerative colitis (ASUC) remains one of the most life-threatening emergencies in inflammatory bowel disease. Despite advances in IBD therapy, first-line management has changed little over the past two decades, and colectomy continues...

FMT in Ulcerative Colitis: JGH | July 2026

Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a rising global burden. Although current therapies are effective, many patients fail treatment or experience adverse effects. Fecal microbiota transplantation (FMT) has emerged as...

Engineering Immune Cell Therapies for IBD: Nat Re Gastroe & Hepato | June 2026

Introduction: Despite major advances with biologics and small molecules, many patients with IBD continue to have refractory disease or lose treatment response. This Perspective explores engineered cellular therapies designed to restore immune tolerance rather than...

Real-World IBD Patients Rarely Meet Clinical Trial Criteria: AJG | June 2026

Introduction: Randomized clinical trials (RCTs) are the cornerstone for approving biologic therapies in inflammatory bowel disease (IBD). However, strict eligibility criteria may exclude many patients encountered in routine clinical practice, raising concerns about the real-world...

Mirikizumab in Ulcerative Colitis: JCC | June 2026

Introduction: Mirikizumab, a selective IL-23p19 inhibitor, has demonstrated efficacy in phase III clinical trials for moderate-to-severe ulcerative colitis (UC). This multicenter Italian real-world study evaluated its effectiveness and safety in routine clinical practice, including patients...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer